Holen Sie sich die Stockscreener-App
0.00
100.00%
-11.13
Schlusskurs vom Vortag:
$11.13
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$994.04M
Einnahmen:
$20.65M
Nettoeinkommen (Verlust:
$-192.65M
KGV:
0.00
EPS:
-2.59
Netto-Cashflow:
$-134.39M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$11.40
Verve Therapeutics Inc Stock (VERV) Company Profile
Firmenname
Verve Therapeutics Inc
Sektor
Branche
Telefon
(978) 501-3026
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie VERV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERV
Verve Therapeutics Inc
|
0.00 | 994.04M | 20.65M | -192.65M | -134.39M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Verve Therapeutics Inc Stock (VERV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-04-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-02-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2022-12-15 | Eingeleitet | Goldman | Sell |
| 2022-10-06 | Eingeleitet | Credit Suisse | Neutral |
| 2022-08-25 | Hochstufung | Stifel | Hold → Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-09-24 | Eingeleitet | Stifel | Hold |
| 2021-07-12 | Eingeleitet | Guggenheim | Buy |
| 2021-07-12 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-12 | Eingeleitet | Jefferies | Buy |
| 2021-07-12 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Verve Therapeutics Inc Aktie (VERV) Neueste Nachrichten
Published on: 2025-08-31 20:32:37 - Newser
Is Verve Therapeutics Inc. stock poised for growthQuarterly Profit Summary & Weekly High Conviction Ideas - Newser
Verve Therapeutics Inc. stock trend forecastPortfolio Performance Report & Stock Market Timing Techniques - Newser
Understanding Verve Therapeutics Inc.’s price movementWeekly Volume Report & AI Driven Price Forecasts - Newser
Real time breakdown of Verve Therapeutics Inc. stock performance2025 Price Action Summary & Step-by-Step Trade Execution Guides - Newser
Does Verve Therapeutics Inc. fit your quant trading modelEarnings Recap Report & AI Forecast Swing Trade Picks - Newser
Will Verve Therapeutics Inc. benefit from macro trendsJuly 2025 Opening Moves & Fast Gaining Stock Reports - Newser
Candlestick signals on Verve Therapeutics Inc. stock todayPortfolio Performance Summary & Stepwise Swing Trade Plans - Newser
How moving averages guide Verve Therapeutics Inc. trading2025 Big Picture & AI Powered Trade Plan Recommendations - Newser
Building trade automation scripts for Verve Therapeutics Inc.M&A Rumor & Real-Time Volume Trigger Notifications - Newser
Predicting Verve Therapeutics Inc. trend using moving averagesJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - Newser
Regression analysis insights on Verve Therapeutics Inc. performanceWeekly Volume Report & AI Driven Price Forecasts - Newser
What’s next for Verve Therapeutics Inc. stock priceLayoff News & Smart Swing Trading Techniques - Newser
What to expect from Verve Therapeutics Inc. in the next 30 daysTrend Reversal & Low Volatility Stock Recommendations - Newser
Will Verve Therapeutics Inc. outperform the market2025 Dividend Review & Accurate Buy Signal Alerts - Newser
Is Verve Therapeutics Inc. stock a good hedge against inflationPortfolio Value Summary & Weekly Consistent Profit Watchlists - Newser
Signal strength of Verve Therapeutics Inc. stock in tech scannersRate Hike & AI Driven Stock Reports - Newser
Verve Therapeutics (VERV) Reported Results From its Heart-2 Phase 1b Trial for VERVE-102 - MSN
Heatmap analysis for Verve Therapeutics Inc. and competitorsDip Buying & Long-Term Safe Return Strategies - Newser
Visual trend scoring systems applied to Verve Therapeutics Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - Newser
What moving averages say about Verve Therapeutics Inc.July 2025 Breakouts & Long-Term Safe Investment Ideas - Newser
Verve Therapeutics Inc. stock chart pattern explainedJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Published on: 2025-08-29 21:34:59 - Newser
Analyzing Verve Therapeutics Inc. with multi timeframe chartsJuly 2025 WrapUp & Low Volatility Stock Suggestions - Newser
News impact scoring models applied to Verve Therapeutics Inc.July 2025 Setups & AI Forecast Swing Trade Picks - Newser
Finanzdaten der Verve Therapeutics Inc-Aktie (VERV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):